Clinical Trial Update: Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients [Phase 1, Phase 2]

View source ↗

Summary

Open-label, dose-escalation study evaluating the safety and tolerability of Acadesine in patients with chronic lymphocytic leukemia (B-CLL) completed in Phase 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Acadesine

Snippet

Sponsor: Advancell - Advanced In Vitro Cell Technologies, S.A. | Conditions: Leukemia, B-Cell, Chronic | Phase 1, Phase 2 | Status: COMPLETED